About Us: Advancing Wound Care Innovation with BioHeal Hydrogel
At BIOHEAL THERAPEUTICS, we are redefining wound care with innovative solutions designed to support optimal healing environments. Our BioHeal Hydrogel, currently unavailable in the United States, is a user friendly, tear-resistant alternative to traditional amnion sheet products. It is intended to save time during application and provide a durable solution for wound care.
Our Commitment to Regenerative Medicine
Through an exclusive worldwide licensing agreement with the Wake Forest Institute for Regenerative Medicine (WFIRM), we leverage advancements amnion-derived technologies to develop products for global markets. These innovations are designed to:
- Support wound closure and tissue repair.
- Enhance protection and healing for chronic wounds and severe burns.
Expanding Our Portfolio of Regenerative Solutions
We are actively advancing our product pipeline with treatments aimed at:
- Improving the wound care experience.
- Simplifying product application.
- Supporting healthcare providers with cost-conscious solutions.
Industry Leadership You Can Trust
Founded by Bruce Anderson and Steve Anderson, BIOHEAL THERAPEUTICS is built on over 30 years of experience in medical device development and human tissue processing. This includes the commercialization of implantable cardiovascular and orthopedic products.
A Legacy of Innovation, Headquartered in Atlanta, Georgia
With headquarters in suburban Atlanta, Georgia, BIOHEAL THERAPEUTICS is committed to delivering proprietary regenerative medical solutions designed to:
- Innovate wound care applications.
- Support effective wound management and tissue regeneration.
Our mission is to empower health care professionals with practical solutions to improve patient outcomes worldwide.
Meet the Team
Bruce Anderson
President & CEO
Bruce Anderson, President/CEO. Prior to cofounding BIOHEAL THERAPEUTICS in 2017, Mr. Anderson had more than 20 years global experience developing, manufacturing, processing and commercializing BioGlue , the number one protein hydrogel surgical adhesive used in cardiovascular surgery in the world, over 20 implantable human cardiovascular and orthopedic tissues as well as Class II and III medical devices. Elected in 2008, Mr. Anderson has served as Vice President of US Sales and Global Marketing for Artivion (formerly CryoLife, Inc.). During this time, he led a team of over 120 people, including all worldwide product marketing functions. From 2002 to 2007, he was Director of US Sales, leading the sales team to double digit growth. CryoLife cardiac tissues revolutionized pediatric cardiac reconstructive surgery and helped save the lives of thousands of children. The company's vascular tissues helped save the limbs of thousands of adults with peripheral vascular disease. CryoLife products have been used in 80 different countries. The company's cryopreserved human tissues and surgical adhesive have been implanted in and improved the lives of about 2 million people. He is a graduate of the University of South Florida at Tampa.
Steve Anderson1939-2023
Mr. Anderson was Chairman of the Board and cofounder of BIOHEAL THERAPEUTICS, LLC from 2017 until his passing in 2023. Mr. Anderson was co-founder, President/CEO of CryoLife, Inc. (now Artivion) from 1984 - 2015. He took the company public on Nasdaq in 1994 and moved it to the NYSE in 1997. Prior to that he was Executive Vice President of Intermedics, Inc. (now Boston Scientific) from 1976 to 1983. From 1973 to 1976 he was President of US Operations for Biotronik, Inc. He was the top sales representative and region manager for Medtronic from 1968 - 1973. He was an entrepreneur, pioneer and leader in the medical device industry. He was a graduate of the University of Minnesota at Minneapolis.